Anesthesia and Respiratory Devices Market: By Product Type (Anaesthesia Devices, Anaesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices), By End User (Hospitals, Emergency Medical Services, Ambulatory Surgical Centers), By Geography (Latin America, North America, Asia Pacific, the Middle East and Africa and Europe)

Anesthesia and Respiratory Devices Market size was valued at USD 26,943.8 million in 2023 and is expected to reach USD 46,991.6 million by 2030, at a significant CAGR of 7.2% from 2024-2030. Anesthesia devices are utilized amid surgeries to control torment, breathing, pulse, bloodstream, and heart rate. A restorative state in patients initiated by utilization of Anaesthesia prompts loss of sensation or mindfulness, which can incorporate absence of pain (alleviation from or avoidance of torment), loss of motion (muscle unwinding), amnesia (loss of memory), or obviousness. Respiratory devices are any equipment or device used for the focus on treatment, diagnosis, management, and control of patients with deficiencies of the respiratory system. Various devices are used for the management of respiratory diseases such as COPD and asthma to manage the airflow. Respiratory disorders are one of the leading causes of death in the world.

Anaesthesia And Respiratory Devices Market is expected to grow at a significant growth rate owing to the prevalence of chronic respiratory diseases. According to World Health Organization (WHO), about 64 Mn people are living with COPD worldwide in 2015 and almost 90% of COPD deaths occur in low-income countries. Anesthesia And Respiratory Devices Market consists of many big players and small players competing to increase their market share. Companies adopting mergers and acquisitions as their key strategies to improve market share. For instance, in May 2017, Royal Philips (Koninklijke Philips N.V.) has signed an agreement to acquire Respiratory Technologies, Inc. to expand its respiratory care business. Furthermore, marketers also focus on new product development and product launches to maximize their market share. For instance, in February 2015, Lupin Limited launched InspiraChamber under a strategic agreement with InspiRX Inc. in the US. This agreement will give Lupin exclusive rights to promote, distribute and market INspiraChamber in the US.